Periprosthetic Fractures of the Femur Treated by Osteosynthesis

July 19, 2022 updated by: Tamas Illes, Brugmann University Hospital

Observational retrospective study on 36 consecutive patients having had surgery for a periprosthetic fracture of the femur between 2010 and 2015.

The goal of the study is to test whether osteosynthesis was a secure choice at a certain age and with any type of Vancouver fracture.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

36

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brussels, Belgium, 1020
        • CHU Brugmann

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Periprosthetic fractures of the femur treated by osteosynthesis

Description

Inclusion Criteria:

  • Consecutive patients having had surgery between 2010 and 2015 within the CHU Brugmann hospital for a periprosthetic fracture of the femur (osteosynthesis).

Exclusion Criteria:

  • Death during surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
periprosthetic fractures of the femur
periprosthetic fractures of the femur treated by osteosynthesis
Fracture reduction and fixation with screws/plates/cables (standard of care)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age
Time Frame: Up to 2-3 days before surgery (pre-surgery radiography)
Demographic data
Up to 2-3 days before surgery (pre-surgery radiography)
Sex
Time Frame: Up to 2-3 days before surgery (pre-surgery radiography)
Demographic data
Up to 2-3 days before surgery (pre-surgery radiography)
Body Mass Index
Time Frame: Up to 2-3 days before surgery (pre-surgery radiography)
Demographic data
Up to 2-3 days before surgery (pre-surgery radiography)
Prosthesis type
Time Frame: Up to 2-3 days before surgery (pre-surgery radiography)
PTH (total hip prosthesis) or BHP (bipolar hip prosthesis)
Up to 2-3 days before surgery (pre-surgery radiography)
Type of fracture
Time Frame: Up to 2-3 days before surgery (pre-surgery radiography)
Type of fracture according to the Vancouver International Classification
Up to 2-3 days before surgery (pre-surgery radiography)
Femoral component
Time Frame: Up to 2-3 days before surgery (pre-surgery radiography)
Need for cement within the femur or not
Up to 2-3 days before surgery (pre-surgery radiography)
Time between 1st surgery and fracture
Time Frame: Up to 2-3 days before surgery (pre-surgery radiography)
Time between 1st surgery and fracture
Up to 2-3 days before surgery (pre-surgery radiography)
Fracture healing
Time Frame: 10 months after surgery
Healing status of the fracture (healed/not healed)
10 months after surgery
Mortality rate
Time Frame: 10 months after surgery
Mortality rate (any causes)
10 months after surgery
Complications rate
Time Frame: 10 months after surgery
Total complications rate (local + systemic + implant)
10 months after surgery
ASA score
Time Frame: During surgery (up to 2 hours)
ASA score
During surgery (up to 2 hours)
Blood loss
Time Frame: During surgery (up to 2 hours)
Blood loss during surgery
During surgery (up to 2 hours)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Laterality
Time Frame: Up to 2-3 days before surgery (pre-surgery radiography)
Prosthesis on the right or on the left side
Up to 2-3 days before surgery (pre-surgery radiography)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dragos Schiopu, MD, CHU Brugmann

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2016

Primary Completion (Actual)

November 23, 2020

Study Completion (Actual)

November 23, 2020

Study Registration Dates

First Submitted

August 1, 2016

First Submitted That Met QC Criteria

August 2, 2016

First Posted (Estimate)

August 3, 2016

Study Record Updates

Last Update Posted (Actual)

July 20, 2022

Last Update Submitted That Met QC Criteria

July 19, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • CHUB-Periprosthetic fractures

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periprosthetic Fracture of the Femur

Clinical Trials on osteosynthesis

3
Subscribe